Skip to main content
SearchLoginLogin or Signup

Review 3: "How does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma Mansoni Elimination as a Public Health Problem by 2030?"

Reviewers highlight the crucial role of mass drug administration (MDA) coverage levels. However, they also point out potential limitations, such as overlooking the influence of snail environments and the effects of genetically differential susceptibility.

Published onMar 18, 2024
Review 3: "How does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma Mansoni Elimination as a Public Health Problem by 2030?"
1 of 2
key-enterThis Pub is a Review of
How does treatment coverage and proportion never treated influence the success of Schistosoma mansoni elimination as a public health problem by 2030?
How does treatment coverage and proportion never treated influence the success of Schistosoma mansoni elimination as a public health problem by 2030?
Description

Abstract Background The 2030 target for schistosomiasis is elimination as a public health problem (EPHP), achieved when the prevalence of heavy intensity infection among school-aged children (SAC) reduces to <1%. To achieve this, the new World Health Organization (WHO) guidelines recommend a broader target of population to include pre-school (pre-SAC) and adults. However, the probability of achieving EPHP should be expected to depend on patterns in repeated uptake of mass drug administration (MDA) by individuals.Methods We employed two individual-based stochastic models to evaluate the impact of school-based and community-wide treatment and calculated the number of rounds required to achieve EPHP for Schistosoma. mansoni by considering various levels of the population never treated (NT). We also considered two age intensity profiles, corresponding to a low and high burden of infection in adults.Results The number of rounds needed to achieve this target depends on the baseline prevalence and the coverage used. For low and moderate transmission areas, EPHP can be achieved within seven years if NT ≤10% and NT <5%, respectively. In high transmission areas, community wide treatment with NT<1% is required to achieve EPHP.Conclusions The higher the intensity of transmission, and the lower the treatment coverage, the lower the acceptable value of NT becomes. Using more efficacious treatment regimens would permit NT values to be marginally higher. A balance between target treatment coverage and NT values may be an adequate treatment strategy depending on the epidemiological setting, but striving to increase coverage and/or minimise NT can shorten programme duration.

RR:C19 Evidence Scale rating by reviewer:

  • Strong. The main study claims are very well-justified by the data and analytic methods used. There is little room for doubt that the study produced has very similar results and conclusions as compared with the hypothetical ideal study. The study’s main claims should be considered conclusive and actionable without reservation.

***************************************

Review: The study uses two mathematical models to assess the importance of people never treated on the likelihood of reaching targets for control of schistosomiasis by mass drug administration. The higher the proportion never treated, the less likely targets are reached, or the longer the duration of treatment required. The result is robust to different settings.

This manuscript is a short summary of the results of modeling to quantify the impact of never-treated proportion of a population on the achievement of goals for control of schistosomiasis. It is informative and clear. I have a few suggestions that the authors could consider, but none are essential for publication. As supplementary materials were unavaialabe, I have not been able to review.

Suggestions on the main text are as follows:

  1. Abstract, Methods: Please describe the full experimental detail, not just that there are two age intensity profiles (i.e. the dimensions of Table 2).

  2. Abstract, Results: Please describe the main results for the different age profiles as well as the baseline prevalence.

  3. Results/Discussion: One of the strengths of this work is the use of two separate models. However, they are not compared in the results or mentioned in the discussion – did they agree? What was the value of using two models? Are they similar because they have the same root (Anderson & Medley, 1983).

  4. Discussion: Some mention of the causes of NT in the discussion would be more complete. Migration/movement is mentioned as a complication, but there is a literature on why people are NT, which could be pointed at.

  5. Discussion: It is not clear how the modeling distributes the NT proportion in terms of age/sex, and how they infect each other. I would expect that the same proportion NT would give different results if randomly distributed through the population compared to all being in the same households/villages. Please expand.

    Minor points:

  1. Introduction, para 2: The abbreviation “PC” is never used, and as I am not sure that “preventive chemotherapy” is correct (it’s just chemotherapy and doesn’t prevent specially in the treated individual) so I suggest removing. It is not included in the Abbreviations.

  2. Table 2: Unless there is an optical illusion in play, there are two shades of grey in the table. Please reduce to one.

  3. Funding: The mention of funding to Hollingsworth is unusual given that they are not an author.

Comments
0
comment
No comments here
Why not start the discussion?